Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector (MARS-NIS)

Recruiting

18 years and older

All

Phase N/A

Simplified description (AI rewritten)
Technical description (Original)

Study duration per participant is approximately 12 weeks

How understandable was the trial content above?

Hard to understand

Easy to understand

Study details

Conditions

Primary Hypercholesterolaemia and Mixed Dyslipidaemia

Atherosclerotic Cardiovascular Disease

Clinical Study Identifier

NCT05129241

Sponsor

Sanofi

Last Modified on

19 September 2022

Contact a study center

Check if you are eligible Enter contact details Select a study center Select best time to contact

Are you above 18?

Yes No

Preview complete

The prescreener preview is complete. You may now close the preview.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.

Study Definition